Serological screening for coeliac disease in adults with Turner's syndrome: Prevalence and clinical significance of endomysium antibody positivity

Department of Endocrinology, University College Hospital, London, UK.
European Journal of Endocrinology (Impact Factor: 4.07). 03/2009; 160(4):675-9. DOI: 10.1530/EJE-08-0846
Source: PubMed


To investigate the prevalence of coeliac disease (CD) in an adult population with Turner's syndrome (TS). Design A clinic population with TS was screened using a serological test for CD.
Two hundred and fifty six patients with TS were included in the study. Five patients had existing diagnoses of CD. The remaining 251 asymptomatic patients were screened using an IgA endomysium antibody (EMA) test. Positive cases were offered endoscopy with duodenal biopsy. HLA typing was undertaken in existing cases and new EMA-positive cases.
Of the 251 patients screened, eight were found to be EMA positive (3.2%). Seven patients proceeded to duodenal biopsy on which all were confirmed histologically to have cluster of differentiation (2.8%). The prevalence of subclinical cluster of differentiation in the population can therefore be estimated between 2.8 and 3.2%. The total population prevalence of CD, including the previously diagnosed cases, is estimated between 4.7 and 5.1%. Ten patients with histologically confirmed cluster of differentiation underwent HLA typing of which eight were HLA-DQ2 positive, one was HLA-DQ8 positive and one was negative to both HLA-DQ2 and HLA-DQ8.
This study demonstrates an increased prevalence of cluster of differentiation in an adult population with TS over the general population. This is consistent with previous data published in paediatric populations.

Download full-text


Available from: Amy Frost, Nov 04, 2014
13 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Typescript. Thesis (M.S.)--Albany Medical Center, Graduate Studies Program, 2006. Bibliography: leaves 29-34
    New England Journal of Medicine 11/2007; 357(17):1731-43. DOI:10.1056/NEJMra071600 · 55.87 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances in the clinical, epidemiological, genetic, and therapeutic aspects of celiac disease have made this condition a superb model of autoimmunity. This review will outline the most significant work that contributed to our current knowledge of the disease. Celiac disease is not confined to the Caucasian population as previously believed; rather its prevalence is approximately 1% worldwide. In addition to the HLA genes, many other genes involved in innate and adaptive immunity, intestinal barrier regulation, and autoimmunity have been identified as integral genetic components of the disease. Based on this information and on a better understanding of celiac disease pathogenesis, novel therapies alternative to the gluten-free diet are currently in advanced phase of development. The outcome of these new findings will most likely have a significant impact in clinical practice, including diagnosis and management of the disease. Furthermore, celiac disease can be used as a unique model to gain more insights on the pathogenesis of autoimmune diseases.
    Current opinion in gastroenterology 12/2008; 24(6):687-91. DOI:10.1097/MOG.0b013e32830edc1e · 4.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 42-years old woman has been suffering from psychomo-tor retardation since early childhood. She needed permanent as-sistance from her family for all basic activities of daily life and never developed neither language skills, nor sphincter control. She has a peculiar face and walks with small steps, without mo-tor deficit. She also presents traits of altered behavior, smiles continuously without apparent cause, and scratches when she is upset. She has severe constipation since childhood (1 deposi-tion/week), and requires frequent intake of laxatives. The body mass index was normal (21 kg/m 2). At age of 11 she presented a picture of herpetiform dermati-tis. She has suffered from epilepsy since adolescence. At first, she had frequent convulsive seizures, mixed with episodes of absence with a myoclonic component. She was also diagnosed of hypothyroidism at age 37, and has been treated since then with substitution therapy. The diagnosis of Angelman syn-drome (AS) was established based on clinical features, and confirmed by fluorescence in situ hybridization (FISH) on the affected region, which showed the presence of a microdeletion in the q11-q13 region of one of the chromosomes 15. The patient came to our clinic 2.5 years ago with the chief complaint of marked food intolerance with frequent nausea and repeated episodes of vomiting and acid reflux. She was unre-sponsive to antiemetics or PPIs. She had a significant fer-ropenic anemia (Hb = 10.4 g/dL), which was refractory to oral iron preparations. A colonoscopy and an upper gastrointestinal (GI) en-doscopy were normal. Duodenal biopsies showed an increase of intraepithelial lymphocytes (LIEs) (> 40%), without vil-lous atrophy (Marsh I). A slightly increased tissue transgluta-minase (3 U/ml) was detected, being DQ2-positive in one al-lele and DQ8-positive in both. Based on the histological, serological, and genetic findings a celiac disease (CD) was diagnosed, and the family was advised to feed the patient with a gluten-free diet (GFD). We also ad-ministered parenteral iron, once/week during 3 months, with to-tal resolution of anemia. The follow-up examinations to date (five in two years and a half overall) show that the patient remains asymptomatic, with-out anemia and improved control of the hypothyroidism and epilepsy, after the first year of the GFD. Constipation has no-tably improved (1 deposition/2 days). Upper GI endoscopy was repeated after 2 years of the GFD, showing that the lymphocy-tic enteritis had resolved with normal appearance of the intesti-nal mucosa (Marsh 0). The follow-up laboratory tests per-formed during these 2 years are shown in table I. The AS is different from the one caused by abnormal pater-nal contribution to the same locus, known as Prader-Willi syn-drome. The genetic basis for AS was described for the first time Table I. Analytical evolution during 2 years of GFD
    Revista espanola de enfermedades digestivas: organo oficial de la Sociedad Espanola de Patologia Digestiva 01/2010; 102(7):450-1. · 1.41 Impact Factor
Show more